authors
- Trudel, S
- Dodgson, C
- Nanji, S
- Li, ZH
- Voralia, M
- Dube, ID
- Graham, Frank Lawson
- Stewart, AK
A phase I study of adenovirus engineered, interleukin 2 (IL-2) secreting, autologous plasma cell vaccination for the treatment of multiple myeloma.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- November 15, 1999
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1114 Paediatrics and Reproductive Medicine (FoR)
- Immunology (Science Metrix)
published in
- Blood Journal